Brief: Neurocrine Biosciences Appoints Lewis Choi As Chief Information Officer
09/06/2025 21:15
Neurocrine Biosciences Inc NBIX.O: NEUROCRINE BIOSCIENCES APPOINTS LEWIS CHOI AS CHIEF INFORMATION OFFICER Source text: ID:nPn12rrQca Further company coverage: NBIX.O
Recent news on Neurocrine Biosciences
See all newsBrief: Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating Nbi-'567 In Adults With Alzheimer's Disease
Nxera Pharma's Partner Neurocrine Biosciences Receives Ind Acceptance From FDA For Phase 2 Study Of Nbi-1117567 For Alzheimer's Cognition
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Prader-Willi groups cite deaths tied to Neurocrine's genetic disorder drug, shares fall